Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Ovarian Carcinoma
23
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00721890
Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Completed · Phase 2
NCT00096200
Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Completed · Phase 2
NCT00181701
Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Ovarian Carcinoma
🏥 Names
Disease Name
Ovarian Carcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms; Endocrine System Diseases
🔗 External References
HERB DB
DisGeNET
C0029925
🔍 Raw view — every non-empty column on this row (21 fields)
name
Ovarian Carcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms; Endocrine System Diseases
umls disease type id
T191
mesh disease class id
C04; C19; C13
herb disease id
HBDIS002253
disgenet id
C0029925
🌿 Related Herbs
1 · shared evidence📋 Clinical Trials
12 · subject of clinical studyNCT00721890 Green Tea Intake for the Maintenance of Complete Remission in Women With Advance
→ Ovarian Carcinoma
NCT00096200 Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With R
→ Recurrent Fallopian Tube Carcinoma|Recurrent Ovari
NCT00181701 Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcin
→ Ovarian Carcinoma
NCT00499252 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With
→ Fallopian Tube Carcinoma|Primary Peritoneal Carcin
NCT00756847 Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplati
→ Cancer|Non-Small Cell Lung Cancer|Endometrial Carc
NCT00814086 Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage I
→ Chemotherapeutic Agent Toxicity|Endometrial Adenoc
NCT00954174 Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnos
→ Mixed Mesodermal (Mullerian) Tumor|Ovarian Carcino
NCT00989651 Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Ne
→ Fallopian Tube Carcinoma|Fallopian Tube Carcinosar
NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevac
→ Borderline Ovarian Mucinous Tumor|Ovarian Mucinous
NCT01091428 Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal C
→ Ovarian Carcinoma|Fallopian Tube Cancer|Peritoneal
NCT01199263 Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or
→ Recurrent Fallopian Tube Carcinoma|Recurrent Ovari
NCT01294293 TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Pacli
→ Malignant Ovarian Mixed Epithelial Tumor|Ovarian B
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables